Wave Life Sciences .(US:WVE) ZACKS·2025-05-08 13:50分组1 - Wave Life Sciences reported a quarterly loss of $0.29 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.27, and compared to a loss of $0.24 per share a year ago, indicating an earnings surprise of -7.41% [1] - The company posted revenues of $9.18 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 34.33%, and down from $12.54 million in the same quarter last year [2] - Wave Life Sciences shares have declined approximately 47.5% since the beginning of the year, contrasting with the S&P 500's decline of -4.3% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.25 on revenues of $18.12 million, and for the current fiscal year, it is -$1.01 on revenues of $66.47 million [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 33% of over 250 Zacks industries, suggesting that the industry outlook can significantly impact stock performance [8]